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1. Introduction 
The glycolytic enzyme, pyruvate kinase (ATP: 
pyruvate phosphotransferase; EC 2.7.1.40) from 
Escherichiu coli cross-reacts immunologically with the 
enzyme from man. Since the divergence of eukaryotes 
and prokaryotes is estimated to have occurred 1.4 billion 
years ago [ 11, this demonstrates remarkable stability of 
the immunological determinants and the responsible 
structural features in this enzyme during evolution. 
The detection of similar molecular structures in E. coli 
and man provides additional support for the concept 
of unity of life at the molecular level [2]. 
2. Materials and methods 
Antisera against the human muscle isozyme [3] the 
human erythrocyte isozyme [4] and the bovine muscle 
isozyme [5] were used as probes for immunological 
similarities. We have previously shown that the human 
muscle and human erythrocyte isozymes do not 
cross-react using either anti-human erythrocyte or 
anti-human muscle isozyme antisera [6]. The anti-human 
muscle isozyme antiserum cross-reacts with the bovine 
muscle isozyme while the erythrocyte isozyme antiserum 
does not. The probes used can distinguish differences 
between mammalian pyruvate kinase isozymes. 
The human erythrocyte pyruvate kinase used was a 
partially purified preparation [7]. The purification of 
the human muscle isozyme has been described else- 
where [3]. 
E. coZi cells were prepared with the growth medium 
described by Waygood and Sanwal [8] from the stock 
culture collection of the Department of Microbiology 
and Immunology. The cells were harvested by centri- 
fugation and then sonicated after the pellets were 
resuspended in cold 2.5 mM NaH2P04, 2.5 mM KH2POa 
pH 7.5, 1 mM KzEDTA and 10 mM 2-mercaptoethanol. 
The two pyruvate kinase isozymes in E. coli were 
separated by DEAE-cellulose (Whatman DE52) 
chromatography [9]. The isozyme eluting first is 
responsive to media changes and is activated by 
fructose-l, 6-diphosphate whereas the second isozyme 
is constitutive [9] and is activated by 5’-AMP and 
other organic monophosphates [lo]. 
A yeast supernatant with pyruvate kinase activity 
was prepared as described by Hunsley and Suettler [ 111. 
3. Results and discussion 
The unfractionated E. coli supernatant formed 
precipitin lines on immunodiffusion with all three 
anti-mammalian enzyme antisera (fig.1). 
Following separation of the two E. coli pyruvate 
kinase activities, enzyme inactivation experiments were 
performed. The inducible enzyme was not inactivated 
by any of the three antisera. The constitutive enzyme 
was partially inactivated by the antisera against the two 
human isozymes but was not inactivated by anti-bovine 
muscle pyruvate kinase (fig.2) which indicates that the 
inactivation by the two anti-human antisera is not due 
to unrelated factors common to all rabbit sera. The 
lack of inactivation by anti-bovine muscle isozyme 
antiserum is in accord with other data indicating that 
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Fig.1. Gel immunodiffusion analysis of K coli supernatant with the three antisera. The method and conditions were as described 
by Campbell et al. [ 171. (A) The wells contained: 1 and 7, human muscle pyruvate kinase, 32 units/ml; 2 and 3, anti-human 
erythrocyte pyruvate kinase; 4, anti-human muscle pyruvate kinase; 5, E. coli supernatant, 0.04 units/ml; 6, human erythrocyte 
pyruvate kinase, 3.0 units/ml. (B) The wells contained; 1, 3 and 6, empty; 2, anti-bovine muscle pyruvate kinase; 4, anti-human 
muscle pyruvate kinase; 5, E. coli supernatant, 2.52 units/ml; 7, human muscle pyruvate kinase, 32 units/ml. 
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Fig.2. Each of the two E. coli pyruvate kinase isozymes was 
tested for antibody inactivation by the three antisera [6]. 
For the constitutive enzyme present in the second peak from 
the DEAE-cellulose column, 1 mM AMP was added to the 
assay mix and the activity was adjusted to 0.26 units/ml. 
The figure shows the constitutive enzyme with: anti-human 
muscle pyruvate kinase (0); anti-human erythrocyte pyruvate 
kinase (m); anti-bovine muscle pyruvate kinase (e). 
this reagent detects some antigenic determinants 
undetectable by anti-human muscle isozyme antiserum 
and vice versa (unpublished). 
Similar experiments with the yeast supernatant 
showed no interaction with any of the antisera. 
The amino acid sequence studies on D-glyceral- 
dehyde 3-phosphate dehydrogenase have permitted 
sequence comparisons of a prokaryote and eukaryote 
glycolytic enzymes [12]. The lobster and pig enzymes 
show 70% residue identity, lobster and yeast 68% while 
there is 51% identity between the sequences of the 
lobster and Bacillus stearothermophilus. 
Immunological studies of cytochrome c [ 131 and 
lysozyme [ 141 from different species indicate that 
immunological cross-reactivity disappears when amino 
acid sequences differ by 30-40%. The immunological 
cross-reactivity between E. coli and mammalian pyruvatc 
kinase, thus, implies considerable sequence homology 
between the isozymes with the homology likely to be 
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in the same range as that observed for D-glyceraldehyde 
3-phosphate dehydrogenase. The human erythrocyte 
and muscle isozymes have evolved to gene products 
sufficiently different so that the proteins do not present 
readily detectable cross-reaction, however, each 
apparently retains some of the ancestral immunological 
determinants present on the constitutive E. coli 
isozyme. 
Cohen et al. [ 151 have proposed that the central 
role of the glycolytic pathway in the metabolism of the 
mature red cell has restricted the evolutionary process 
acting on erythrocyte glycolytic enzymes. Mutations 
are highly likely to be detrimental and, therefore, 
selected against. It is interesting to note that it is the 
constitutive isozyme in E. coli which retains 
determinants recognized by both human antisera. By 
similar reasoning, the basic necessity for a functional 
constitutive enzyme is likely to restrict acceptable 
mutations and cause a slow rate of evolution. From 
comparisons of amino acid compositions we have 
suggested that the rate of divergent evolution of the 
pyruvate kinase isozymes has been slower than that 
observed for cytochrome c [ 161. The immunological 
evidence presented here is consistent with that idea. 
Convergent evolution to give the same results seem 
less likely. DNA exchange between eukaryote and 
prokaryote, while topical, would be a rather unlikely 
explanation. 
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